XML 61 R35.htm IDEA: XBRL DOCUMENT v3.6.0.2
Selected Quarterly Financial Information (UNAUDITED) (Tables)
 12 Months Ended
Dec. 31, 2016
Selected Quarterly Financial Information (UNAUDITED) [Abstract]  
Selected Quarterly Financial Information
The consolidated operating results in any quarter are not necessarily indicative of the consolidated results that may be expected for any future period.

Year Ended December 31, 2016
 
First
Quarter
  
Second
Quarter
  
Third
Quarter
  
Fourth
Quarter
 
Revenues, net
 
$
1,848
  
$
1,171
  
$
1,441
  
$
1,103
 
Operating expenses
  
25,606
   
15,574
   
10,996
   
12,356
 
Loss from operations
  
(23,758
)
  
(14,403
)
  
(9,555
)
  
(11,253
)
Net income (loss) attributable to BioTime, Inc.
  
(17,112
)
  
24,549
   
31,199
   
(4,945
)
                 
Basic and diluted net income (loss) per share
 
$
(0.19
)
 
$
0.26
  
$
0.30
  
$
(0.05
)
                 
Year Ended December 31, 2015
                
Revenues, net
 
$
1,000
  
$
1,749
  
$
1,874
  
$
1,306
 
Operating expenses
  
14,502
   
15,245
   
18,978
   
23,013
 
Loss from operations
  
(13,502
)
  
(13,496
)
  
(17,104
)
  
(21,707
)
Net loss attributable to BioTime, Inc.(1)
  
(10,167
)
  
(9,691
)
  
(13,626
)
  
(13,507
)
                 
Basic and diluted net loss per share
 
$
(0.13
)
 
$
(0.12
)
 
$
(0.18
)
 
$
(0.16
)

(1)
Net of $4.5 million of deferred income tax benefits for 2015, entirely attributable to Asterias.